<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sarandakou, A.</style></author><author><style face="normal" font="default" size="100%">Agroyannis, B.</style></author><author><style face="normal" font="default" size="100%">Rizos, D.</style></author><author><style face="normal" font="default" size="100%">Kapetanaki, A.</style></author><author><style face="normal" font="default" size="100%">Founta, P.</style></author><author><style face="normal" font="default" size="100%">Phocas, I.</style></author><author><style face="normal" font="default" size="100%">Koutsikos, D.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Soluble interleukin-2 receptor (sIL-2R) and β2-microglobulin (β2M) serum levels in renal transplant recipients (RTR)</style></title><secondary-title><style face="normal" font="default" size="100%">Dialysis and Transplantation</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">1993</style></year><pub-dates><date><style  face="normal" font="default" size="100%">1993///</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">22</style></volume><pages><style face="normal" font="default" size="100%">246 - 250</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">The authors conclude that serum levels of sIL-2R and β2M may play a role in the early diagnosis and identification of patients with chronic rejection.</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue></record></records></xml>